Iwata Hiroo, Arima Yusuke, Tsutsui Yusuke
Compass to Healthy Life Research Complex Program, RIKEN, Kobe, Japan.
Institute for Life and Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
Artif Organs. 2018 Aug;42(8):E168-E185. doi: 10.1111/aor.13106. Epub 2018 Apr 2.
A bioartificial pancreas (BAP), in which islets of Langerhans (islets) are enclosed in a semipermeable membrane, has been developed to realize islet transplantation without the use of immunosuppressive drugs. Although recent progress in induced pluripotent stem (iPS) and embryonic stem (ES) cells has attracted attention owing to the potential applications of these cells as insulin-releasing cells, concerns about the safety of implantation of these cells remain. The use of the BAP has the advantage of easy removal if insulin-releasing cells derived from iPS/ES cells undesirably proliferate and form tumors in the BAP. Oxygen supply is a crucial issue for cell survival in BAPs as insufficient oxygen supply causes central necrosis of cell aggregates. In this study, we derived several simple equations considering oxygen supply in BAPs in order to provide insights into the rational design of three different types of BAPs (spherical microcapsules, cylindrical capsules, and planar capsules). The equations give (i) the thickness of a capsule membrane leading to no central necrosis of encapsulated cell aggregates as a function of the original size of the cell aggregate; (ii) the oxygen concentration profiles in BAPs; (iii) the effects of encapsulation of a cell aggregate on insulin release; (iv) the amount of encapsulated cells required to normalize blood glucose levels of a patient; and (v) the total volumes and sizes of BAPs. As an example, we used the equations in order to design three different types of BAPs for subcutaneous implantation.
生物人工胰腺(BAP)是将胰岛包裹在半透膜中制成的,其目的是在不使用免疫抑制药物的情况下实现胰岛移植。尽管诱导多能干细胞(iPS)和胚胎干细胞(ES)的研究进展因其作为胰岛素分泌细胞的潜在应用而备受关注,但这些细胞植入的安全性问题仍然存在。如果源自iPS/ES细胞的胰岛素分泌细胞在BAP中异常增殖并形成肿瘤,BAP具有易于移除的优势。氧气供应是BAP中细胞存活的关键问题,因为氧气供应不足会导致细胞聚集体中心坏死。在本研究中,我们推导了几个考虑BAP中氧气供应的简单方程,以便深入了解三种不同类型BAP(球形微胶囊、圆柱形胶囊和平面胶囊)的合理设计。这些方程给出了:(i)作为细胞聚集体原始大小函数的、能使被包裹细胞聚集体不发生中心坏死的胶囊膜厚度;(ii)BAP中的氧气浓度分布;(iii)细胞聚集体封装对胰岛素释放的影响;(iv)使患者血糖水平正常化所需的封装细胞数量;以及(v)BAP的总体积和尺寸。作为示例,我们使用这些方程来设计三种不同类型的用于皮下植入的BAP。